A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection
NCT00002119 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the clinical toxicity, safety, and MTD of WF 10 ( TCDO ) intravenous solution administered to patients with HIV infection. To evaluate the potential anti-HIV activity of TCDO.
Conditions
- HIV Infections
Interventions
- DRUG
-
WF10
Sponsors & Collaborators
-
Oxo Chemie GmbH
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
NCT00002023 ·Status: COMPLETED ·Phase: NA
-
A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex
NCT00000710 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
NCT00000652 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT00002337 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CI-1012 in HIV-Infected Patients
NCT00002196 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
NCT00002280 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
NCT00002312 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
NCT00002385 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets
NCT02993237 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of 524W91
NCT00002335 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
NCT00046332 ·Status: COMPLETED ·Phase: PHASE2
-
Tenofovir Rectal Douche to Prevent HIV Transmission
NCT04016233 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002338 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
NCT00001032 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
NCT00002311 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DPC 817 in HIV-Infected Males
NCT00040274 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus
NCT00361101 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
NCT00000812 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.
NCT00000629 ·Status: COMPLETED ·Phase: PHASE1
-
Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects
NCT00000740 ·Status: COMPLETED ·Phase: PHASE1
-
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
NCT00002001 ·Status: COMPLETED ·Phase: NA
-
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002141 ·Status: COMPLETED ·Phase: PHASE1